Chronic News and Research

RSS

Vitamin K prevents age-related conditions

An important analysis conducted by Children's Hospital Oakland Research Institute scientists suggests the importance of ensuring optimal dietary intakes of vitamin K to prevent age-related conditions such as bone fragility, arterial and kidney calcification, cardiovascular disease, and possibly cancer. Vitamin K is concentrated in dark green plants such as spinach or Swiss chard, and is either not present or present in only small amounts in most multivitamin pills.

18 Sep 2009

AAPA applauds Baucus' efforts to move forward on health care reform legislation

The American Academy of Physician Assistants (AAPA), representing 75,000 clinically practicing physician assistants (PAs) in the United States, is very pleased that America's Healthy Future Act of 2009, produced yesterday by Senator Max Baucus, fully integrates PAs into new team-based models of care that are designed to promote primary care and the coordination of care for patients with chronic medical conditions.

18 Sep 2009

AFA welcomes inclusion of cognitive impairment screening in healthcare reform proposal

The Alzheimer's Foundation of America (AFA) today applauded Senate Finance Committee Chairman Max Baucus (D-MT) and Senator Tom Carper (D-DE), who spearheaded the provision, for including cognitive impairment screening for Medicare beneficiaries in Baucus' healthcare reform proposal, "America's Healthy Future Act of 2009."

18 Sep 2009

PSC activation mechanisms help develop novel therapeutic approaches for pancreatic fibrosis

Fibrosis is a key feature of chronic pancreatitis and pancreatic cancer. The extensive deposition of extracellular matrix proteins fosters the development of an exocrine and endocrine organ insufficiency, and accelerates progression of the tumour. Pancreatic stellate cells (PSC) are the principal effector cells in pancreatic fibrosis. They are activated by profibrogenic mediators, which include, for example, cytokines and ethanol metabolites.

18 Sep 2009

Study reveals that caregivers are unable to diagnose the pain levels affecting nursing home residents

Relatives and healthcare staff find it hard to diagnose pain levels in nursing home residents accurately, especially if they are cognitively impaired with illnesses such as dementia or unable to speak, according to a study in September issue of the Journal of Clinical Nursing.

18 Sep 2009

Medicare to create pilot program for medical home model

Medicare will create a pilot program for a "medical home" model. The Wall Street Journal reports: "The Obama administration said Medicare will help fund state pilot projects that use primary-care doctors and teams of coordinators to manage patient care and reduce costs. Under the 'medical home' model, pioneered in Vermont and several other states, physicians are paid more for coordinating care for their patients.

17 Sep 2009

Canada's health care associations urge health ministers to tackle pressing issues at the ministers' annual meeting

Canada's leading health care associations are calling on federal and provincial/territorial health ministers to tackle a number of pressing issues at the ministers' annual meeting, taking place in Winnipeg September 17.

17 Sep 2009

Study: HBV genotype is not linked to hepatocellular carcinoma

Previous studies revealed that HBV genotypes as well as mutations in the core promoter, precore or HBx gene have been shown to have an association with the clinical outcome of liver disease, however, this is still controversial. It is likely that this depends on the HBV genotype distribution in certain region.

17 Sep 2009

Educational initiative proves successful in identifying and diagnosing fibromyalgia

According to The Johns Hopkins University School of Medicine, the Fibromyalgia Circle of Care Initiative has achieved dramatic success in heightening awareness, diagnosis and best practice treatment of fibromyalgia – a complex and chronic pain disorder that plagues an estimated 10 million Americans.

17 Sep 2009

American Lung Association applauds EPA’s decision to reduce threat from dangerous air pollutant

Today the Administrator of the U.S. Environmental Protection Agency, Lisa Jackson, announced that the Agency will embark on a formal review of the national air quality standard for ozone, a decision that offers the opportunity to finally protect the health of millions of Americans from the most widespread and one of the most dangerous air pollutants.

17 Sep 2009

NIH to fund grants for epigenetic research

The National Institutes of Health announced today that it will fund 22 grants on genome-wide studies of how epigenetic changes -- chemical modifications to genes that result from diet, aging, stress, or environmental exposures -- define and contribute to specific human diseases and biological processes.

17 Sep 2009

PFCD health care reform panel calls for promoting health through prevention of chronic diseases

The Partnership to Fight Chronic Disease (PFCD) today brought together several health care experts to discuss ways to "get back to the basics" in health reform by advancing legislation that promotes the health of all Americans through better prevention and management of chronic disease.

17 Sep 2009

Vista Health System and MedVentive to offer sophisticated medical solution to patients and physicans

Vista Health System, LLC is pleased to announce a partnership with MedVentive, the leading provider of integrated performance management solutions for providers and health plans, to provide information technology services to its member physicians to improve patient care.

17 Sep 2009

Bayer HealthCare to present its clinical trial data at a joint Multidisciplinary Congress

Bayer HealthCare today announced that data from more than 30 clinical trials evaluating three products in the company's oncology portfolio - Nexavar(R) (sorafenib) tablets, regorafenib (BAY 73-4506) and Alpharadin(TM) - will be presented at the joint 15th European CanCer Organisation (ECCO) and 34th European Society for Medical Oncology (ESMO) Multidisciplinary Congress, September 20-24, 2009 in Berlin, Germany.

17 Sep 2009

SI-BONE's summit to develop clinical diagnostic process for SI Joint pathology identification

SI-BONE, Inc. a San Francisco Bay-area, medical device company, announced the first ever meeting of thought leading spine surgeons to review data and develop a clinical diagnostic process for identification of SI Joint pathology, a frequent cause of low back pain.

17 Sep 2009

FDA issues a complete response letter for Sanofi-aventis' eplivanserin NDA

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the company's New Drug Application (NDA) for eplivanserin (Ciltyri(R)). Eplivanserin was reviewed as a potential treatment for patients with chronic insomnia characterized by difficulties with sleep maintenance.

17 Sep 2009

Weis Markets to hold low-cost flu shot program

Beginning this month, Weis Markets will hold more than 100 low-cost flu shot clinics in its Maryland, New Jersey, Pennsylvania and West Virginia stores. In addition, as part of its WEISCARE Adult Immunization program, many Weis Markets' pharmacies will offer flu shots as an on-going service.

17 Sep 2009

Melbourne's national approach for managing chronic pain

An unprecedented gathering of some of Australia's leading authorities in pain medicine, together with consumer groups representing chronic pain sufferers, will meet in Melbourne today to work towards a national, coordinated approach to managing chronic pain.

17 Sep 2009

APP Pharmaceuticals announces FDA marketing approval of Deferoxamine Mesylate

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Deferoxamine Mesylate for Injection, USP, in two dosage strengths. Deferoxamine Mesylate is therapeutically equivalent to the reference-listed drug Desferal®, which is marketed by the innovator Novartis.

17 Sep 2009

FDA provides 510(k) marketing clearance for the FlexStent Biliary Self Expanding Stent System

Flexible Stenting Solutions Inc. (“FSS”), a leading developer of next generation peripheral arterial and biliary stents, received 510(k) clearance for the FlexStent® Biliary Self Expanding Stent System.

17 Sep 2009

Chronic News and Research

Vitamin K prevents age-related conditions

AAPA applauds Baucus' efforts to move forward on health care reform legislation

AFA welcomes inclusion of cognitive impairment screening in healthcare reform proposal

PSC activation mechanisms help develop novel therapeutic approaches for pancreatic fibrosis

Study reveals that caregivers are unable to diagnose the pain levels affecting nursing home residents

Medicare to create pilot program for medical home model

Canada's health care associations urge health ministers to tackle pressing issues at the ministers' annual meeting

Study: HBV genotype is not linked to hepatocellular carcinoma

Educational initiative proves successful in identifying and diagnosing fibromyalgia

American Lung Association applauds EPA’s decision to reduce threat from dangerous air pollutant

NIH to fund grants for epigenetic research

PFCD health care reform panel calls for promoting health through prevention of chronic diseases

Vista Health System and MedVentive to offer sophisticated medical solution to patients and physicans

Bayer HealthCare to present its clinical trial data at a joint Multidisciplinary Congress

SI-BONE's summit to develop clinical diagnostic process for SI Joint pathology identification

FDA issues a complete response letter for Sanofi-aventis' eplivanserin NDA

Weis Markets to hold low-cost flu shot program

Melbourne's national approach for managing chronic pain

APP Pharmaceuticals announces FDA marketing approval of Deferoxamine Mesylate

FDA provides 510(k) marketing clearance for the FlexStent Biliary Self Expanding Stent System

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News